The value of chemical fat-saturation pulse added to T1-weighted spin-echo sequence in evaluating gadolinium-enhancing brain lesions in multiple sclerosis;Lesioni encefaliche con contrast-enhancement in pazienti affetti da sclerosi multipla: Confronto tra sequenze spin-echo T1-pesate convenzionali e con saturazione spettrale del grasso

Radiologia Medica

Volumn 112, Issue 8, 2007, Pages 1244-1251

  Sardanelli, F ^a   Schiavoni, S ^b   Iozzelli, A ^a   Fausto, A ^a   Aliprandi, A ^a   Mancardi, G L ^c   Filippi, M ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b Biomedical Institute   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Brain Gd enhancement; Fat saturation; MR imaging; Multiple sclerosis

Indexed keywords

GADODIAMIDE; GADOLINIUM;

ADULT; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM; SINGLE DRUG DOSE;

ADULT; BRAIN; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 38349052172     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0220-y     Document Type: Article

References (35)

1. Fazekas F, Barkhof F, Filippi M et al (1999) The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 53:448-456
2. Katz D, Taubenberger JK, Cannella B et al (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34:661-669
3. Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059-2069
4. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121-127
5. Molyneux PD, Miller DH (1999) Magnetic resonance imaging techniques to monitor phase III treatment trials. In: Filippi M, Grossman RI, Comi G (eds) Magnetic resonance techniques in clinical trials in multiple sclerosis. Springer, Milano, pp 49-73
6. Losseff N, Kingsley DPE, McDonald WI et al (1996) Clinical and magnetic resonance predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler 1:218-222
7. Koudriavtseva T, Thompson AJ, Fiorelli M et al (1997) Gadolinium enhanced MRI disease activity in relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 62:285-287
8. Filippi M (2000) Enhanced magnetic resonance imaging in multiple sclerosis. Mult Scler 6:320-326
9. Sardanelli F, Losacco C, Iozzelli A et al (2002) Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer. Eur Radiol 12:2077-2082
10. Sardanelli F, Iozzelli A, Losacco C et al (2003) Three subsequent single doses of Gd-chelate in brain MR of multiple sclerosis. AJNR Am J Neuroradiol 24:658-662
11. Delfaut EM, Beltran J, Johnson G et al (1999) Fat suppression in MR imaging: techniques and pitfalls. Radiographics 19:373-382
12. Fujii Y, Konishi Y, Kuriyama M et al (1993) Lipoma on surface of centroparietal lobes. Pediatr Neurol 9:144-166
13. Dahlen RT, Johnson CE, Harnsberger HR et al (2002) CT and MR imaging characteristics of intravestibular lipoma. AJNR Am J Neuroradiol 23:1413-1417
14. Sener RN (1995) Isolated choroid plexus lipomas. Comput Med Imaging Graph 19:423-426
15. Mirowitz SA, Apicella P, Reinus WR, Hammerman AM (1994) MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fatsuppressed T2-weighted, and STIR images. AJR Am J Roentgenol 162:215-221
16. Seitz J, Held P, Strotzer M et al (2002) MR imaging of cranial nerve lesions using six different high-resolution T1- and T2(*)-weighted 3D and 2D sequences. Acta Radiol 43:349-353
17. Guy J, Mao J, Bidgood WD Jr, Mancuso A, Quisling RG (1992) Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging. Ophthalmology 99:713-719
18. Sklar EM, Schatz NJ, Glaser JS et al (1996) MR of vasculitis-induced optic neuropathy. AJNR Am J Neuroradiol 17:121-128
19. Jackson A, Sheppard S, Laitt RD et al (1998) Optic neuritis: MR imaging with combined fat- and water-suppression techniques. Radiology 206:57-63
20. Okamoto K, Ito J, Ogawa R et al (1999) Bilateral optic neuritis in a child diagnosed with Gd-enhanced MR imaging using fat-suppression technique. Eur Radiol 9:731-733
21. Barkhof F (1996) Role of MR imaging in the diagnosis of MS. Ad MRI Contrast 4:31-38
22. Namer IJ, Yu O, Mauss Y, Dumitresco BE, Chambron J (1993) An evaluation of the significance of areas of intense signal in the MR brain images of patients with multiple sclerosis. Magn Reson Imaging 11:311-317
23. Hashemi RH, Bradley WG, Chen DY et al (1995) Suspected multiple sclerosis: MR imaging with a thin-section fast Flair pulse sequence. Radiology 196:505-510
24. Filippi M, Yousry T, Baratti C et al (1996) Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 119:1349-1355
25. Truyen L, van Waesberghe JH, van Walderveen MA et al (1996) Accumulation of hypointense lesion ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469-1476
26. van Waesberghe JH, Kamphorst W, De Groot CJ et al (1999) Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 46:747-754
27. Van Waesberghe JH (1996) Magnetization transfer ratio and contrast in multiple sclerosis. Ad MRI contrast 4:54-60
28. Renzetti P, Parodi RC, Losacco C et al (1999) Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration. Radiol Med 98:138-143
29. Bastianello S, Gasperini C, Paolillo A et al (1998) Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast. AJNR Am J Neuroradiol 19:1863-1867
30. Filippi M, Rovaris M, Capra R et al (1998) A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 121:2011-2020
31. Rovaris M, Codella M, Moiola L et al (2002) Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology 59:1429-1432
32. Mancardi GL, Saccardi R, Filippi M et al (2001) Cell transplantation for multiple sclerosis. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57:62-68
33. Rovaris M, Filippi M (2000) Contrast enhancement and the acute lesion in multiple sclerosis. Neuroimaging Clin N Am 10:705-716
34. Mao J, Yan H, Brey WW (1993) Fat tissue and fat suppression. Magn Reson Imaging 11:385-393
35. Jackson EF, Ginsberg LE, Schomer DF, Leeds NE (1997) A review of MRI pulse sequences and techniques in neuroimaging. Surg Neurol 47:185-199